Ameriprise
LJPC

Ameriprise’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Ameriprise’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-34,495
Closed -$134K – 3961
2020
Q4 		$134K Sell
34,495
-38,470
-53% -$164K ﹤0.01% 3662
2020
Q3 		$294K Buy
72,965
+14,937
+26% +$61.9K ﹤0.01% 3431
2020
Q2 		$245K Buy
+58,028
New +$353K ﹤0.01% 3425
2015
Q4 		– Sell
-43,873
Closed -$1.22M – 4061
2015
Q3 		$1.22M Buy
+43,873
New +$1.38M ﹤0.01% 2889

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameriprise's LJPC Position: Q1 2021 in Review

Ameriprise sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2021, closing a stake of 34,495 shares — an estimated $134K sold.

Ameriprise first reported a position in LJPC in Q3 2015 and held it in 4 quarters. The position peaked at $1.22M in Q3 2015. 76 funds tracked by Wall St. Rank hold LJPC as of Q1 2021.

  • Ameriprise reported no remaining La Jolla Pharmaceutical Company position as of Q1 2021 after selling out during the quarter.
  • Ameriprise sold 34,495 La Jolla Pharmaceutical Company shares in Q1 2021, an estimated $134K.
  • Ameriprise first reported a position in La Jolla Pharmaceutical Company in Q3 2015 and held it in 4 quarters.
  • Ameriprise's La Jolla Pharmaceutical Company position peaked at $1.22M in Q3 2015.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2021.

Based on Ameriprise's 13F filing for Q1 2021, filed 17 May 2021.